- Home
- ILAG vs NEPH Comparison
ILAG vs NEPH Comparison
Compare ILAG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- NEPH
- Stock Information
- Founded
- ILAG 1981
- NEPH 1997
- Country
- ILAG Hong Kong
- NEPH United States
- Employees
- ILAG N/A
- NEPH N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- NEPH Medical/Dental Instruments
- Sector
- ILAG Consumer Discretionary
- NEPH Health Care
- Exchange
- ILAG Nasdaq
- NEPH Nasdaq
- Market Cap
- ILAG 18.4M
- NEPH 15.4M
- IPO Year
- ILAG 2022
- NEPH 2004
- Fundamental
- Price
- ILAG $1.01
- NEPH $1.56
- Analyst Decision
- ILAG
- NEPH Buy
- Analyst Count
- ILAG 0
- NEPH 1
- Target Price
- ILAG N/A
- NEPH $5.00
- AVG Volume (30 Days)
- ILAG 15.2K
- NEPH 8.3K
- Earning Date
- ILAG 11-29-2024
- NEPH 11-07-2024
- Dividend Yield
- ILAG N/A
- NEPH N/A
- EPS Growth
- ILAG N/A
- NEPH N/A
- EPS
- ILAG N/A
- NEPH N/A
- Revenue
- ILAG $6,443,357.00
- NEPH $13,546,000.00
- Revenue This Year
- ILAG N/A
- NEPH N/A
- Revenue Next Year
- ILAG N/A
- NEPH $7.39
- P/E Ratio
- ILAG N/A
- NEPH N/A
- Revenue Growth
- ILAG N/A
- NEPH 0.03
- 52 Week Low
- ILAG $0.33
- NEPH $1.36
- 52 Week High
- ILAG $1.35
- NEPH $4.04
- Technical
- Relative Strength Index (RSI)
- ILAG 46.95
- NEPH 52.07
- Support Level
- ILAG $0.96
- NEPH $1.39
- Resistance Level
- ILAG $1.07
- NEPH $1.67
- Average True Range (ATR)
- ILAG 0.05
- NEPH 0.05
- MACD
- ILAG -0.00
- NEPH 0.02
- Stochastic Oscillator
- ILAG 36.50
- NEPH 60.71
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.